Central administration of the muscarinic receptor subtype-selective antagonist pirenzepine selectively impairs passive avoidance learning in the mouse.
D000700:Analgesics; D000818:Animals; D001362:Avoidance Learning / Q000187:drug effects*; D001570:Benzodiazepinones / Q000494:pharmacology*; D001831:Body Temperature / Q000187:drug effects; D008297:Male; D051379:Mice; D010095:Oxotremorine / Q000037:antagonists & inhibitors; D010890:Pirenzepine; D011950:Receptors, Cholinergic / Q000187:drug effects*; D011976:Receptors, Muscarinic / Q000187:drug effects*
D000700:Analgesics; D001570:Benzodiazepinones; D011950:Receptors, Cholinergic; D011976:Receptors, Muscarinic; D010890:Pirenzepine; D010095:Oxotremorine